241 related articles for article (PubMed ID: 26860935)
1. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract][Full Text] [Related]
2. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
Parmer M; Milan S; Torabi A
Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
5. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
[TBL] [Abstract][Full Text] [Related]
6. Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge.
Sukpanich R; Khanafshar E; Suh I; Gosnell J
AME Case Rep; 2019; 3():12. PubMed ID: 31231713
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid on 68Ga DOTANOC PET-CT.
Tripathy S; Aggrawal S; Subudhi K; Kumar R; Narwal A
Clin Nucl Med; 2019 Sep; 44(9):e546-e547. PubMed ID: 31283604
[TBL] [Abstract][Full Text] [Related]
9. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
10. Compact buds with biphasic differentiation and calcitonin-expressing neuroendocrine cells-previously unrecognized structures of thyroglossal duct unveiled by immunohistochemistry.
Keelawat S; Bychkov A
Virchows Arch; 2019 May; 474(5):609-617. PubMed ID: 30729310
[TBL] [Abstract][Full Text] [Related]
11. A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid.
Kim GY; Park CY; Cho CH; Park JS; Jung ED; Jeon EJ
Endocrinol Metab (Seoul); 2015 Jun; 30(2):221-5. PubMed ID: 25491784
[TBL] [Abstract][Full Text] [Related]
12. Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer.
Chorny JA; Orrego JJ; Cameselle-Teijeiro JM
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29692901
[TBL] [Abstract][Full Text] [Related]
13. Isolated carcinoid tumor metastatic to the thyroid gland: report of a case initially diagnosed by fine needle aspiration cytology.
Maly A; Meir K; Maly B
Acta Cytol; 2006; 50(1):84-7. PubMed ID: 16514846
[TBL] [Abstract][Full Text] [Related]
14. Radiation-associated small cell neuroendocrine carcinoma of the thyroid: a case report with molecular analyses.
Mussazhanova Z; Miura S; Stanojevic B; Rougounovitch T; Saenko V; Shiraishi T; Kurashige T; Shichijo K; Kaneko K; Takahashi H; Ito M; Nakashima M
Thyroid; 2014 Mar; 24(3):593-8. PubMed ID: 23844610
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract][Full Text] [Related]
16. [PREOPERATIVE DIAGNOSTICS OF THYROID MEDULLARY CARCINOMA WITH EMPHASIS ON CYTOMORPHOLOGICAL FEATURES AND DIFFERENTIAL DIAGNOSIS OF PRIMARY AND SECONDARY THYROID TUMORS].
Katović SK; Vasilj A
Acta Med Croatica; 2014 Dec; 68(4-5):383-8. PubMed ID: 26285471
[TBL] [Abstract][Full Text] [Related]
17. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.
Bhanot P; Yang J; Schnadig VJ; Logroño R
Diagn Cytopathol; 2007 May; 35(5):285-92. PubMed ID: 17427218
[TBL] [Abstract][Full Text] [Related]
18. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
Hirsch MS; Faquin WC; Krane JF
Mod Pathol; 2004 Jun; 17(6):631-6. PubMed ID: 15098009
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
Seok JY; Kang M; De Peralta-Venturina M; Fan X
Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
[TBL] [Abstract][Full Text] [Related]
20. [Medullary thyroid carcinoma].
Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
